
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| ISRG | +6.48% | +124.24% | +17.53% | +27,233% |
| S&P | +17.53% | +93.66% | +14.13% | +363% |
Intuitive Surgical makes and maintains the da Vinci robotic device, an advanced surgical system that lets surgeons perform minimally invasive surgery.
Intuitive Surgical crushed earnings expectations in October, and the stock soared. Is this high-flying robotic surgery leader still worth buying at these prices?
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $2.51B | 22.9% |
| Gross Profit | $1.66B | 21.0% |
| Gross Margin | 66.36% | -1.1% |
| Market Cap | $160.32B | -8.2% |
| Market Cap / Employee | $10.25M | 0.0% |
| Employees | 15.6K | 14.3% |
| Net Income | $709.20M | 24.3% |
| EBITDA | $919.70M | 32.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $2.81B | 16.3% |
| Accounts Receivable | $1.26B | 9.3% |
| Inventory | 1.8K | 20.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.00M | 0.0% |
| Short Term Debt | $0.00M | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 14.81% | 1.0% |
| Return On Invested Capital | 12.89% | -0.5% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $735.60M | 60.4% |
| Operating Free Cash Flow | $841.00M | 19.0% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 81.39 | 72.65 | 75.83 | 59.20 | -25.03% |
| Price to Book | 11.93 | 10.75 | 11.39 | 8.98 | -24.31% |
| Price to Sales | 22.74 | 20.72 | 21.64 | 16.83 | -25.68% |
| Price to Tangible Book Value | 12.22 | 10.99 | 11.63 | 9.17 | -24.71% |
| Price to Free Cash Flow TTM | 145.68 | 103.46 | 99.21 | 71.24 | -76.57% |
| Enterprise Value to EBITDA | 216.58 | 245.01 | 214.35 | 170.72 | -31.98% |
| Free Cash Flow Yield | 0.7% | 1.0% | 1.0% | 1.4% | 326.82% |
| Return on Equity | 15.6% | 15.9% | 16.0% | 16.9% | 5.92% |
| Total Debt | $146.00M | $0.00M | $0.00M | $0.00M | - |

Discussing earnings from the restaurant and healthcare space, plus two stocks our interns are keeping an eye on.

Robotic surgery is on fire as a new Intuitive Surgical competitor is about to come public via a SPAC merger.

Is 5G here or is it just hype? What does it take for a successful 5G rollout?

Recurring revenue, monopolistic market positions, and returns that tend to beat even the risky biotechs tie these three together.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.